1413999

Methotrexat-Systemeignungslösung

United States Pharmacopeia (USP) Reference Standard

• NACRES: NA.24
• UNSPSC Code: 41116107
• eCl@ss: 25140904

Eigenschaften

• grade: pharmaceutical primary standard
• agency: USP
• API family: methotrexate
• manufacturer/tradename: USP
• application(s): pharmaceutical; pharmaceutical (small molecule)
• format: mixture
• storage temp.: 2-8°C

Beschreibung

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Methotrexate System Suitability Mixture USP reference standard suitable for use in specified USP compendial tests and assays.

Also used to prepare system suitability solutions during the impurity analysis of Methotrexate.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• Gefahrencodes: H301,H315,H319,H341,H360D,H372
• Sicherheitshinweise: P202 - P260 - P264 - P301 + P310 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 3 Oral - Eye Irrit. 2 - Muta. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 1
• Zielorgane: Liver,Bone marrow
• Lagerklasse: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3